Clinical Trial Update: A Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Romosozumab (AMG 785) [Phase 1]

View source ↗

Summary

Phase 1 multiple-dose study evaluating safety, tolerability, pharmacokinetics, and pharmacodynamics of romosozumab in adults with postmenopausal osteopenia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postmenopausal Osteoporosis

Drugs mentioned

• Romosozumab (romosozumab)

Snippet

Sponsor: Amgen | Conditions: Postmenopausal, Osteopenia | Phase 1 | Status: COMPLETED | Results posted: 2019-07-05